A single copy of this article may be reprinted for personal, noncommercial use only.
NuvaRing (vaginal ring)By Mayo Clinic staff
Original Article: http://www.mayoclinic.com/health/nuvaring/MY01008
CLICK TO ENLARGE
NuvaRing is a hormonal birth control (contraceptive) device for women. A flexible, transparent plastic ring, NuvaRing is inserted deep into the vagina and worn for three weeks. You remove NuvaRing for one week — allowing menstruation to occur — then insert a new ring.
Similar to combination birth control pills, NuvaRing prevents pregnancy by releasing hormones into your body. NuvaRing suppresses ovulation — keeping your ovaries from releasing an egg. NuvaRing also thickens cervical mucus to keep sperm from reaching the egg.
NuvaRing is the only vaginal hormonal contraceptive that's approved by the Food and Drug Administration (FDA) and available in the U.S. To use NuvaRing, you'll need a prescription from your health care provider.
Why it's done
NuvaRing helps prevent pregnancy. Among various benefits, NuvaRing:
- Can be removed at any time, followed by a quick return to fertility
- Doesn't require a personalized fitting
- Eliminates the need to interrupt sex for contraception
- Is safe for women with latex allergies
NuvaRing isn't appropriate for everyone, however. Your health care provider may discourage use of NuvaRing if:
- You're about to be immobilized for a prolonged period due to major surgery
- You are breast-feeding or recently gave birth, had a miscarriage, or had an abortion
- You're older than age 35 and smoke
- You're sensitive to any components of NuvaRing
- You have diabetes and vascular-related complications
- You have a history of blood clots
- You have a history of breast, uterine or liver cancer
- You have a history of heart attack or stroke
- You have liver disease
- You have migraines with aura
- You have severe high blood pressure
- You have unexplained vaginal bleeding
- You had jaundice during pregnancy or previous use of hormonal contraceptives
- The vaginal ring repeatedly falls out after insertion
In addition, tell your health care provider if you have:
- A dropped (prolapsed) uterus or bladder, or rectal prolapse
- A history of toxic shock syndrome
- Any condition that makes you susceptible to vaginal irritation
- Breast lumps, fibrocystic disease or an abnormal mammogram, or a family history of breast cancer
- Epilepsy or migraine headaches
- Gallbladder, liver, heart or kidney disease
- High cholesterol or triglycerides
- High blood pressure
- Irregular periods
- Plans to have surgery
- Severe constipation
The vaginal ring doesn't offer protection from sexually transmitted infections (STIs).
An estimated 5 out of 100 women will get pregnant in the first year of using NuvaRing.
Side effects of NuvaRing may include:
- An increased risk of blood-clotting problems, heart attack, stroke, liver cancer, gallbladder disease and high blood pressure
- Breakthrough bleeding or spotting
- Fluid retention
- Vaginal infection or irritation
- Vaginal secretion
- Weight gain
- Decreased sex drive
- Breast tenderness
Call your health care provider as soon as possible if you have:
- Breast lumps
- Foul vaginal odor or vaginal itching
- Irregular vaginal bleeding during more than one menstrual cycle
- New or worsening headaches
- Signs or symptoms of a blood clot in your leg, such as persistent pain in your calf
- Signs or symptoms of toxic shock syndrome, such as a sudden fever, vomiting, diarrhea, dizziness, fainting or a rash
- Signs or symptoms of jaundice, such as yellowing of the skin or whites of the eyes, especially with fever, fatigue, loss of appetite, dark urine or light-colored bowel movements
- Signs or symptoms of depression, such as trouble sleeping, fatigue or feeling sad
- Two missed periods or other signs of pregnancy
How you prepare
You'll need to request a prescription for NuvaRing from your health care provider. Your health care provider will review your medical history and check your blood pressure. Talk to your health care provider about any medications you're taking, including nonprescription and herbal products.
Your health care provider will determine the appropriate timing for you to start using NuvaRing based on your menstrual cycle and your previous birth control method. You may need to take a pregnancy test and use a nonhormonal backup method of contraception for one week when you start using NuvaRing.
A backup method of contraception may not be necessary if you previously used combination birth control pills or the skin patch (Ortho Evra) and insert NuvaRing on any day up to the day you would have started your new pack of pills or applied a new skin patch.
What you can expect
CLICK TO ENLARGE
To use NuvaRing:
- Insert NuvaRing. Remove NuvaRing from its foil pouch. Find a position that's comfortable, such as standing with one leg up, squatting or lying down. Separate your labia with one hand. With your other hand, squeeze together the opposite sides of NuvaRing between your thumb and index finger. Gently push NuvaRing deep inside your vagina. The exact placement of the ring doesn't change its effectiveness. If you feel discomfort, try pushing NuvaRing deeper inside your vagina. Keep the ring in place for three weeks. You don't need to remove NuvaRing during sex.
- Gently remove NuvaRing. After three weeks of continuous use, gently remove NuvaRing. Hook your index finger under the rim of the ring or grasp the ring between your index finger and middle finger and gently pull it out. Discard NuvaRing. Don't flush it down the toilet. Wait one week to insert a new ring. You'll typically have withdrawal bleeding two to three days after removing the ring. You may still be bleeding when you insert the new ring. If you locate NuvaRing in your vagina but can't remove it, consult your health care provider.
- If NuvaRing falls out, reinsert it. NuvaRing can be expelled during tampon removal, sex or a bowel movement. If NuvaRing accidentally falls out, rinse the ring with cool or warm — not hot — water and reinsert it within three hours.
- If NuvaRing remains outside of your vagina for longer than three hours, use backup contraception. If this happens during the first or second week of NuvaRing use, reinsert NuvaRing as soon as possible and use a backup method of contraception for a week. If this happens during the third week of NuvaRing use, discard the ring. You can start using a new ring right away, which may cause breakthrough spotting or bleeding. Use a backup method of contraception until you use the new ring continuously for seven days. Or, if you used NuvaRing continuously for the previous seven days, you can wait up to seven days from the time the ring was removed or expelled to insert a new ring. You'll have withdrawal bleeding. Use a backup method of contraception until you use the new ring continuously for seven days.
You can use a tampon while using the NuvaRing. NuvaRing, however, can interfere with the placement of a diaphragm. Don't use a diaphragm as a backup method of birth control while using NuvaRing. If a ring breaks, discard it and use a new ring.
- Combined (estrogen & progestin) contraceptives. In: Zieman M, et al. A Pocket Guide to Managing Contraception. Tiger, Ga.: Bridging the Gap Foundation; 2010:114.
- Zieman M. Overview of contraception. http://www.uptodate.com/home/index.html. Accessed Nov. 18, 2011.
- Birth control methods fact sheet. U.S. Department of Health and Human Services. http://www.womenshealth.gov/publications/our-publications/fact-sheet/birth-control-methods.cfm. Accessed Nov. 18, 2011.
- Implants, injections, rings, and patches: Hormonal birth control options. American College of Obstetricians and Gynecologists. http://www.acog.org/publications/faq/faq159.cfm. Accessed Nov. 18, 2011.
- Nanda K. Contraceptive patch and vaginal contraceptive ring. In: Hatcher RA, et al. Contraceptive Technology. 20th ed. New York, N.Y.: Ardent Media; 2011.
- NuvaRing (prescribing information). Roseland, N.J.: Organon USA Inc.; 2008. http://www.nuvaring.com/hcp/global/prescribing-information.asp. Accessed Nov. 18, 2011.
- NuvaRing. U.S. Food and Drug Administration. http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails. Accessed Nov. 18, 2011.